• Phone: +1-631-791-1145
  • Email: sales@imarcgroup.com

*As the coronavirus disease (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

mRNA Vaccines and Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The global mRNA vaccines and therapeutics market potential is expected to reach a value of US$ 9.41 Billion in 2021. Messenger Ribonucleic Acid (mRNA) refers to a single protein-coding gene in the genome that acts as a basis for protein synthesis within the cells. mRNA vaccines and therapeutics combine the desirable immunological properties and are prepared in laboratories using mammalian cells. Some of the common types of vaccines and therapeutics include self-amplifying, non-replicating, in vivo self-replicating and in vitro dendritic cell non-replicating mRNA. They are injected into the body to trigger virus-detecting immune sensors and produce viral antigen proteins within the cells. This aids in enhancing the body’s immunity by improving B- and T-cell responses.

The rising prevalence of medical ailments, such as diabetes, tuberculosis, cancer and cardiovascular diseases (CVDs), is one of the key factors driving the growth of the market. The increasing demand for therapeutic medicines and vaccines for Ebola, influenza, Human Immunodeficiency Virus (HIV) and other viral infections is also providing a boost to the market growth. In comparison to conventional medicines, mRNA vaccines and therapeutics are developed using advanced technologies that are more effective against pathogens, have higher potency, enhanced immunogenicity and are relatively more cost-effective. Additionally, improvements in the lipid nanoparticle formulations for in-vivo systemic delivery of mRNA are also creating a positive outlook for the market. Pharmaceutical companies are investing in mRNA technologies as they can combine multiple molecules into a therapeutic medicine, which is acting as another major growth-inducing factor. Other factors, including extensive research and development (R&D) activities in the field of biotechnology, along with improvements in the healthcare technologies, are projected to drive the market further. Looking forward, the market is projected to register a CAGR of 10.5% during 2021-2026, reaching a value of US$ 15.49 Billion by 2026.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global mRNA vaccines and therapeutics market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, vehicle type, product type and technology.

Breakup by Vaccine Type:

  • Self-amplifying mRNA-based Vaccines
  • Conventional Non-Amplifying mRNA-Based Vaccines
     

Breakup by Treatment Type:

  • Bioengineered Vaccine
  • Gene Therapy 
  • Gene Transcription 
  • Cell Therapy
  • Monoclonal Antibody
  • Others
     

Breakup by Vaccine Manufacturing:

  • In-House
  • Out-Sourced
     

Breakup by Application:

  • Cancer
  • Infectious Disease
  • Gene Editing
  • Protein Replacement
     

Breakup by End-User:

  • Hospitals and Clinics
  • Research Organizations
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

 

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Arcturus Therapeutics Inc., BioNTech SE, CureVac AG, Etherna, ethris GmbH, GlaxoSmithKline PLC, Moderna Therapeutics Inc., Translate Bio Inc., Argos Therapeutics, Inc., Sangamo Therapeutics Inc., Pfizer Inc, etc.

Key Questions Answered in This Report:

  • How the global mRNA vaccines and therapeutics market will perform in the coming years?
  • What will be the key regional markets?
  • What will be the impact of COVID-19 on the mRNA vaccines and therapeutics market?
  • What will be the key vaccine types in the market?
  • What will be the key treatment types in the market?
  • What will be the key manufacturing types in the market?
  • What will be the applications in the market?
  • What will be the key end-use segments in the market?
  • What would be the various stages in the value chain of the industry?
  • What will be the key driving factors and challenges in the industry?
  • What will be the structure of the global mRNA vaccines and therapeutics market and who will be the key players?
  • What would be the degree of competition in the industry?

1    Preface
2    Scope and Methodology 

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Introduction to mRNA Vaccines and Therapeutics
    5.1    History of mRNA Vaccines and Therapeutics Development
    5.2    Incidence and Prevalence of Chronic Diseases and Major Infectious Diseases
    5.3    Prevention and Treatment Using mRNA Vaccines and Therapeutics
        5.3.1 mRNA Modifications
        5.3.2 mRNA Efficiencies
        5.3.3 Adjuvant/Stimulant and Carrier Technologies for mRNA-Based Vaccines
        5.3.4 Carriers for mRNA-Based Protein and Antibody Therapeutics
6    Global mRNA Vaccines and Therapeutics Market
    6.1 Market Potential Overview
    6.2 Market Potential
    6.3 Impact of COVID-19
    6.4 mRNA Vaccines in Pipeline
7    Market Breakup by Vaccine Type
    7.1 Self-amplifying mRNA Based Vaccine
    7.2 Conventional Non-Amplifying mRNA-Based Vaccines
8    Market Breakup by Treatment Type
    8.1 Gene Therapy
    8.2 Monoclonal Antibody
    8.3 Gene Transcription 
    8.4 Cell Therapy  
    8.5 Bioengineering Vaccine
    8.6 Others
9    Market Breakup by Vaccine Manufacturing
    9.1 In-House
    9.2 Out-Sourced
10    Market Breakup by Application
   10.1 Cancer
   10.2 Infectious Disease
   10.3 Gene Editing
   10.4 Protein Replacement
11    Market Breakup by End-User
     11.1 Hospitals and Clinics
     11.2 Research Organizations
     11.3 Others
12    Market Breakup by Region
     12.1 North America
       12.1.1 Market Breakup by Country
         12.1.1.1 United Sates
         12.1.1.2 Canada
     12.2 Europe
       12.2.1 Market Breakup by Country
         12.2.1.1 Germany
         12.2.1.2 United Kingdom
         12.2.1.3 France
         12.2.1.4 Italy
         12.2.1.5 Spain
         12.2.1.6 Russia
         12.2.1.7 Others
     12.3 Asia Pacific
       12.3.1 Market Breakup by Country
         12.3.1.1 Japan
         12.3.1.2 China
         12.3.1.3 Australia
         12.3.1.4 South Korea
         12.3.1.5 India
         12.3.1.6 Indonesia
         12.3.1.7 Others
    12.4 Latin America
       12.4.1 Market Breakup by Country
         12.4.1.1 Brazil
         12.4.1.2 Mexico
         12.4.1.3 Others
    12.5 Middle East and Africa
       12.5.1 Market Breakup by Country
13    SWOT Analysis
    13.1    Overview
    13.2    Strengths
    13.3    Weaknesses
    13.4    Opportunities
    13.5    Threats
14    Value Chain Analysis
15    Porters Five Forces Analysis

    15.1    Overview
    15.2    Bargaining Power of Buyers
    15.3    Bargaining Power of Suppliers
    15.4    Degree of Competition
    15.5    Threat of New Entrants
    15.6    Threat of Substitutes
16    Competitive Landscape
    16.1 Market Structure
    16.2 Key Players
    16.3 Profiles of Key Players
       16.3.1 Arcturus Therapeutics, Inc.
       16.3.2 BioNTech SE
       16.3.3 CureVac AG
       16.3.4 eTheRNA
       16.3.5 ethris GmbH
       16.3.6 GlaxoSmithKline PLC 
       16.3.7 Moderna Therapeutics Inc.,
       16.3.8 Translate Bio Inc.
       16.3.9 Argos Therapeutics, Inc.
       16.3.10 Sangamo Therapeutics Inc.,
       16.3.11 Pfizer Inc. 

List of Figures

Figure 1: Global: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Billion US$), 2021-2026
Figure 2: Global: mRNA Vaccines and Therapeutics Market Potential (Self-amplifying mRNA Based Vaccine): Value Trends (in Billion US$), 2021-2026
Figure 3: Global: mRNA Vaccines and Therapeutics Market Potential (Conventional Non-Amplifying mRNA-Based Vaccines): Value Trends (in Billion US$), 2021-2026
Figure 4: Global: mRNA Vaccines and Therapeutics Market Potential (Gene Therapy): Value Trends (in Billion US$), 2021-2026
Figure 5: Global: mRNA Vaccines and Therapeutics Market Potential (Monoclonal Antibody): Value Trends (in Billion US$), 2021-2026
Figure 6: Global: mRNA Vaccines and Therapeutics Market Potential (Gene Transcription): Value Trends (in Billion US$), 2021-2026
Figure 7: Global: mRNA Vaccines and Therapeutics Market Potential (Cell Therapy): Value Trends (in Billion US$), 2021-2026
Figure 8: Global: mRNA Vaccines and Therapeutics Market Potential (Bioengineered Vaccine): Value Trends (in Billion US$), 2021-2026
Figure 9: Global: mRNA Vaccines and Therapeutics Market Potential (Other Treatment Types): Value Trends (in Billion US$), 2021-2026
Figure 10: Global: mRNA Vaccines and Therapeutics Market Potential (In-House): Value Trends (in Billion US$), 2021-2026
Figure 11: Global: mRNA Vaccines and Therapeutics Market Potential (Outsourced): Value Trends (in Billion US$), 2021-2026
Figure 12: Global: mRNA Vaccines and Therapeutics Market Potential (Cancer): Value Trends (in Billion US$), 2021-2026
Figure 13: Global: mRNA Vaccines and Therapeutics Market Potential (Infectious Disease): Value Trends (in Billion US$), 2021-2026
Figure 14: Global: mRNA Vaccines and Therapeutics Market Potential (Gene Editing): Value Trends (in Billion US$), 2021-2026
Figure 15: Global: mRNA Vaccines and Therapeutics Market Potential (Protein Replacement): Value Trends (in Billion US$), 2021-2026
Figure 16: Global: mRNA Vaccines and Therapeutics Market Potential (Hospitals and Clinics): Value Trends (in Billion US$), 2021-2026
Figure 17: Global: mRNA Vaccines and Therapeutics Market Potential (Research Organizations): Value Trends (in Billion US$), 2021-2026
Figure 18: Global: mRNA Vaccines and Therapeutics Market Potential (Other end users): Value Trends (in Billion US$), 2021-2026
Figure 19: North America: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Billion US$), 2021-2026
Figure 20: North America: mRNA Vaccines and Therapeutics Market Potential: Breakup by Country (in %), 2021
Figure 21: United States: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2021-2026
Figure 22: Canada: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2021-2026
Figure 23: Europe: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Billion US$), 2021-2026
Figure 24: Europe: mRNA Vaccines and Therapeutics Market Potential: Breakup by Country (in %), 2021
Figure 25: Germany: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2021-2026
Figure 26: United Kingdom: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2021-2026
Figure 27: France: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2021-2026
Figure 28: Italy: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2021-2026
Figure 29: Spain: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2021-2026
Figure 30: Russia: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2021-2026
Figure 31: Others: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2021-2026
Figure 32: Asia Pacific: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Billion US$), 2021-2026
Figure 33: Asia Pacific: mRNA Vaccines and Therapeutics Market Potential: Breakup by Country (in %), 2021
Figure 34: Japan: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2021-2026
Figure 35: China: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2021-2026
Figure 36: Australia: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2021-2026
Figure 37: South Korea: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2021-2026
Figure 38: India: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2021-2026
Figure 39: Indonesia: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2021-2026
Figure 40: Others: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2021-2026
Figure 41: Latin America: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Billion US$), 2021-2026
Figure 42: Latin America: mRNA Vaccines and Therapeutics Market Potential: Breakup by Country (in %), 2021
Figure 43: Brazil: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2021-2026
Figure 44: Mexico: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2021-2026
Figure 45: Others: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2021-2026
Figure 46: Middle East and Africa: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Billion US$), 2021-2026
Figure 47: Middle East and Africa: mRNA Vaccines and Therapeutics Market Potential: Breakup by Country (in %), 2021
Figure 48:  Global: mRNA Vaccines and Therapeutics Market: SWOT Analysis
Figure 49:  Global: mRNA Vaccines and Therapeutics Market: Value Chain Analysis
Figure 50:  Global: mRNA Vaccines and Therapeutics Market: Porter’s Five Forces Analysis


List of Tables

Table 1: Global: mRNA Vaccines and Therapeutics Market Potential: Key Industry Highlights, 2021 and 2026
Table 2: Global: mRNA Vaccines and Therapeutics Market: List of Pipeline mRNA Vaccines
Table 3: Global: mRNA Vaccines and Therapeutics Market Potential: Breakup by Vaccine Type (in Billion US$), 2021-2026
Table 4: Global: mRNA Vaccines and Therapeutics Market Potential: Breakup by Treatment Type (in Billion US$), 2021-2026
Table 5: Global: mRNA Vaccines and Therapeutics Market Potential: Breakup by Vaccine Manufacturing (in Billion US$), 2021-2026
Table 6: Global: mRNA Vaccines and Therapeutics Market Potential: Breakup by Application (in Billion US$), 2021-2026
Table 7: Global: mRNA Vaccines and Therapeutics Market Potential: Breakup by End User (in Billion US$), 2021-2026
Table 8: Global: mRNA Vaccines and Therapeutics Market Potential: Breakup by Region (in Billion US$), 2021-2026
Table 9: Global: mRNA Vaccines and Therapeutics Market: Competitive Structure
Table 10: Global: mRNA Vaccines and Therapeutics Market: List of Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-702-409-7331 )
( India: +91-120-433-0800 )


Drop us an email at

sales@imarcgroup.com

Social Links